治疗抑郁和物质使用：一项随机对照试验。
Treating depression and substance use: a randomized controlled trial.
机构信息
Drug Policy Research Center, RAND, Santa Monica, CA 90407, USA.
出版信息
J Subst Abuse Treat. 2012 Sep;43(2):137-51. doi: 10.1016/j.jsat.2011.12.004. Epub 2012 Feb 1.
Abstract
Few integrated substance use and depression treatments have been developed for delivery in outpatient substance abuse treatment settings. To meet the call for more "transportable" interventions, we conducted a pilot study to test a group cognitive-behavioral therapy (CBT) for depression and substance use that was designed for delivery by outpatient substance abuse treatment counselors. Seventy-three outpatient clients were randomized to usual care enhanced with group CBT or usual care alone and assessed at three time points (baseline and 3 and 6 months postbaseline). Our results demonstrated that the treatment was acceptable and feasible for delivery by substance abuse treatment staff despite challenges with recruiting clients. Both depressive symptoms and substance use were reduced by the intervention but were not significantly different from the control group. These results suggest that further research is warranted to enhance the effectiveness of treatment for co-occurring disorders in these settings.
摘要
很少有针对门诊药物滥用治疗环境的综合性药物使用和抑郁治疗方法。为了满足对更“可移植”干预措施的需求，我们进行了一项试点研究，以测试一种专为门诊药物滥用治疗顾问提供的团体认知行为疗法（CBT），用于治疗抑郁和药物使用问题。73 名门诊患者被随机分配到接受团体 CBT 增强的常规护理或单独接受常规护理，并在三个时间点（基线和基线后 3 个月和 6 个月）进行评估。我们的结果表明，尽管在招募患者方面存在挑战，但该治疗方法对于药物滥用治疗人员来说是可以接受和可行的。干预措施降低了抑郁症状和物质使用，但与对照组没有显著差异。这些结果表明，有必要进一步研究以提高这些环境中同时存在的疾病的治疗效果。
相似文献
1
Treating depression and substance use: a randomized controlled trial.
J Subst Abuse Treat. 2012 Sep;43(2):137-51. doi: 10.1016/j.jsat.2011.12.004. Epub 2012 Feb 1.
2
Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial.
J Consult Clin Psychol. 2012 Jun;80(3):404-15. doi: 10.1037/a0028208. Epub 2012 Apr 30.
3
Training addiction counselors to implement CBT for depression.
Adm Policy Ment Health. 2011 Jul;38(4):313-23. doi: 10.1007/s10488-011-0359-7.
4
Quality of Outpatient Depression Treatment in Patients With Comorbid Substance Use Disorder.
Am J Psychiatry. 2021 May 1;178(5):414-423. doi: 10.1176/appi.ajp.2020.20040454. Epub 2020 Oct 29.
5
An effectiveness trial of group cognitive behavioral therapy for patients with persistent depressive symptoms in substance abuse treatment.
Arch Gen Psychiatry. 2011 Jun;68(6):577-84. doi: 10.1001/archgenpsychiatry.2011.53.
6
Evaluation of the Integrated Intervention for Dual Problems and Early Action Among Latino Immigrants With Co-occurring Mental Health and Substance Misuse Symptoms: A Randomized Clinical Trial.
JAMA Netw Open. 2019 Jan 4;2(1):e186927. doi: 10.1001/jamanetworkopen.2018.6927.
7
Developing an integrated treatment for substance use and depression using cognitive-behavioral therapy.
J Subst Abuse Treat. 2009 Dec;37(4):412-20. doi: 10.1016/j.jsat.2009.04.006. Epub 2009 Jun 21.
8
Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: the life enhancement treatment for substance use (LETS Act!).
J Clin Psychiatry. 2008 Jan;69(1):122-9. doi: 10.4088/jcp.v69n0116.
9
Debt Counselling for Depression in Primary Care: an adaptive randomised controlled pilot trial (DeCoDer study).
Health Technol Assess. 2017 Jun;21(35):1-164. doi: 10.3310/hta21350.
10
The impact of depression on the outcome of addictions treatment.
J Subst Abuse Treat. 1998 Mar-Apr;15(2):123-30. doi: 10.1016/s0740-5472(97)00183-9.
引用本文的文献
1
Feasibility in Community Mental Health Research: A Scoping Review.
Adm Policy Ment Health. 2025 Jun 29. doi: 10.1007/s10488-025-01457-8.
2
Resilience and relapse risk in Emirate adult patients with substance use disorder: a national cross-sectional study from the United Arab Emirates.
Front Psychiatry. 2024 Sep 24;15:1444233. doi: 10.3389/fpsyt.2024.1444233. eCollection 2024.
3
The influence of therapy quality on outcomes from behavioural activation and guided self-help treatments for depression in adults with intellectual disabilities.
Br J Clin Psychol. 2025 Jun;64(2):139-147. doi: 10.1111/bjc.12502. Epub 2024 Sep 3.
4
Individual Prediction of Optimal Treatment Allocation Between Electroconvulsive Therapy or Ketamine using the Personalized Advantage Index.
Res Sq. 2023 Nov 30:rs.3.rs-3682009. doi: 10.21203/rs.3.rs-3682009/v1.
5
Randomized controlled trial of telephone monitoring with psychiatry inpatients with co-occurring substance use and mental health disorders.
Drug Alcohol Depend. 2019 Jan 1;194:230-237. doi: 10.1016/j.drugalcdep.2018.09.010. Epub 2018 Oct 29.
6
Outcomes of an integrated care pathway for concurrent major depressive and alcohol use disorders: a multisite prospective cohort study.
BMC Psychiatry. 2018 Jun 13;18(1):189. doi: 10.1186/s12888-018-1770-3.
7
Major depressive disorder and access to health services among people who use illicit drugs in Vancouver, Canada.
Subst Abuse Treat Prev Policy. 2018 Jan 19;13(1):3. doi: 10.1186/s13011-018-0142-9.
8
Bayesian models for semicontinuous outcomes in rolling admission therapy groups.
Psychol Methods. 2017 Dec;22(4):725-742. doi: 10.1037/met0000135.
9
RCT of an integrated CBT-HIV intervention on depressive symptoms and HIV risk.
PLoS One. 2017 Dec 14;12(12):e0187180. doi: 10.1371/journal.pone.0187180. eCollection 2017.
10
Does group cognitive-behavioral therapy module type moderate depression symptom changes in substance abuse treatment clients?
J Subst Abuse Treat. 2014 Jul;47(1):78-85. doi: 10.1016/j.jsat.2014.02.005. Epub 2014 Mar 1.
本文引用的文献
1
Support for Students Exposed to Trauma: A Pilot Study.
School Ment Health. 2009 Jun 1;1(2):49-60. doi: 10.1007/s12310-009-9007-8.
2
Can paraprofessionals deliver cognitive-behavioral therapy to treat anxiety and depressive symptoms?
Bull Menninger Clin. 2010 Winter;74(1):45-62. doi: 10.1521/bumc.2010.74.1.45.
3
A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence.
Am J Psychiatry. 2010 Jun;167(6):668-75. doi: 10.1176/appi.ajp.2009.08060852. Epub 2010 Mar 15.
4
Dynamic association between negative affect and alcohol lapses following alcohol treatment.
J Consult Clin Psychol. 2009 Aug;77(4):633-44. doi: 10.1037/a0015647.
5
Developing an integrated treatment for substance use and depression using cognitive-behavioral therapy.
J Subst Abuse Treat. 2009 Dec;37(4):412-20. doi: 10.1016/j.jsat.2009.04.006. Epub 2009 Jun 21.
6
Psychoeducational treatment and prevention of depression: the "Coping with Depression" course thirty years later.
Clin Psychol Rev. 2009 Jul;29(5):449-58. doi: 10.1016/j.cpr.2009.04.005. Epub 2009 Apr 18.
7
A comparison of two depressive symptomatology measures in residential substance abuse treatment clients.
J Subst Abuse Treat. 2009 Oct;37(3):318-25. doi: 10.1016/j.jsat.2009.03.005. Epub 2009 Apr 8.
8
Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature.
BMC Psychiatry. 2009 Feb 20;9:6. doi: 10.1186/1471-244X-9-6.
9
Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
Harv Rev Psychiatry. 2009;17(1):24-34. doi: 10.1080/10673220902724599.
10
Disparities in use of mental health and substance abuse services by persons with co-occurring disorders.
Psychiatr Serv. 2009 Feb;60(2):217-23. doi: 10.1176/ps.2009.60.2.217.
Zotero 插件